This analysis of the RE-VERSE AD study provides insights to physicians into the role of idarucizumab in the management of dabigatran-related major gastrointestinal bleeding.
Read More..This study provided external validation of the novel biomarker-based ABC-stroke and ABC-bleeding scores for risk stratification of patients with atrial fibrillation.
Read More..Stay Updated. Practice with Knowledge